Description

Diaglizid MR (gliclazide) tablets with prolonged release 30 mg. №30

Ingredients

Active ingredient: Gliclazide 30 mg.
Other ingredients: [List other ingredients here]

Dosage

Adults: The usual dose is 30 mg once daily with breakfast. Your doctor may adjust the dose based on your blood sugar levels.

Indications

Diaglizid MR tablets are indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and weight reduction alone have not been successful in controlling blood sugar levels.

Contraindications

Do not take Diaglizid MR tablets if you are allergic to gliclazide or any other ingredients in the formulation. It is not recommended for use in type 1 diabetes or diabetic ketoacidosis.

Directions

Take Diaglizid MR tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence

Gliclazide, the active ingredient in Diaglizid MR tablets, belongs to the sulfonylurea class of antidiabetic agents. Studies have shown that gliclazide helps stimulate insulin release from the pancreas, thereby reducing blood sugar levels in patients with type 2 diabetes. Research published in the Journal of Diabetes Investigation has demonstrated the efficacy of gliclazide in improving glycemic control and reducing the risk of diabetic complications.

Additional Information

It is important to monitor your blood sugar levels regularly while taking Diaglizid MR tablets to ensure optimal control of diabetes. Inform your doctor about any changes in your health status or if you experience any unusual symptoms. Maintain a healthy lifestyle with proper diet and exercise to complement the effects of the medication.

Diaglizid MR tablets with prolonged release 30 mg offer a convenient once-daily dosing regimen for individuals with type 2 diabetes. The extended-release formulation helps maintain steady drug levels in the body, reducing the risk of hypoglycemia. Clinical trials have shown that gliclazide not only effectively lowers blood glucose levels but also has a low incidence of side effects compared to other antidiabetic medications.

Patients using Diaglizid MR tablets should be aware of the potential for hypoglycemia, especially when combined with other antidiabetic agents. It is essential to follow your healthcare provider’s instructions closely and seek medical advice if you experience symptoms of low blood sugar such as sweating, dizziness, or confusion. Overall, Diaglizid MR tablets provide a reliable option for managing type 2 diabetes with proven efficacy and safety profiles.